ExodusPoint Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.86M | Buy |
+16,545
| New | +$2.86M | 0.03% | 565 |
|
|
2023
Q4 | – | Sell |
-13,743
| Closed | -$1.29M | – | 1382 |
|
|
2023
Q3 | $1.29M | Buy |
+13,743
| New | +$1.29M | 0.01% | 822 |
|
|
2021
Q3 | – | Sell |
-1,936
| Closed | -$255K | – | 2036 |
|
|
2021
Q2 | $255K | Sell |
1,936
-1,040
| -35% | -$137K | ﹤0.01% | 1760 |
|
|
2021
Q1 | $384K | Buy |
2,976
+1,657
| +126% | +$214K | 0.01% | 1475 |
|
|
2020
Q4 | $220K | Buy |
+1,319
| New | +$220K | ﹤0.01% | 1610 |
|
|
2019
Q4 | – | Sell |
-13,482
| Closed | -$1.3M | – | 1457 |
|
|
2019
Q3 | $1.3M | Sell |
13,482
-16,009
| -54% | -$1.54M | 0.05% | 304 |
|
|
2019
Q2 | $3.4M | Sell |
29,491
-13,463
| -31% | -$1.55M | 0.14% | 86 |
|
|
2019
Q1 | $5.06M | Buy |
+42,954
| New | +$5.06M | 0.38% | 43 |
|